Label: DOCOSANOL cream

  • NDC Code(s): 51672-1406-2, 51672-1406-3
  • Packager: Taro Pharmaceuticals U.S.A., Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated November 16, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Docosanol 10%

  • Purpose

    Cold sore/fever blister treatment

  • Uses

    • treats cold sores/fever blisters on the face or lips
    • shortens healing time and duration of symptoms:
    • tingling, pain, burning, and/or itching
  • Warnings

    Allergy alert

    This product may cause a severe allergic reaction. Symptoms may include:

    • hives
    • facial swelling
    • wheezing/difficulty breathing
    • shock
    • rash

    If an allergic reaction occurs, stop use and seek medical help right away.

    For external use only

    Do not use

    • if you are allergic to any ingredient in this product

    When using this product

    • apply only to affected areas
    • do not use in or near the eyes
    • avoid applying directly inside your mouth
    • do not share this product with anyone. This may spread infection.

    Stop use and ask a doctor if

    • your cold sore gets worse or the cold sore is not healed within 10 days

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • adults and children 12 years or over:
      • wash hands before and after applying cream
      • apply to affected area on face or lips at the first sign of cold sore/fever blister (tingle)
      • early treatment ensures the best results
      • rub in gently but completely
      • use 5 times a day until healed
    • children under 12 years: ask a doctor
  • Other information

    • store between 20° to 25°C (68° to 77°F)
    • do not freeze
  • Inactive ingredients

    benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate and sucrose stearate

  • Questions or comments?

    call 1-866-923-4914

  • SPL UNCLASSIFIED SECTION

    TAMPER-EVIDENT: DO NOT USE IF THE SEAL ON THE TUBE IS PUNCTURED OR NOT VISIBLE

  • SPL UNCLASSIFIED SECTION

    Dist. by: Taro Pharmaceuticals U.S.A., Inc.
    Hawthorne, NY 10532

  • PRINCIPAL DISPLAY PANEL - 2 g Tube Package

    NDC 51672-1406-3

    Compare to the active
    ingredient in Abreva®*

    Docosanol
    Cream 10%

    Cold Sore
    Fever Blister
    Treatment

    Cold Sore
    Treatment

    Only FDA
    Approved
    Medicine to
    Shorten
    Healing Time✝

    For Topical Use Only

    Net Wt. 2 g (0.07 oz)

    Dist. by: Taro Pharmaceuticals U.S.A., Inc.
    Hawthorne, NY 10532 Made in Canada

    PRINCIPAL DISPLAY PANEL - 2 g Tube Package
  • INGREDIENTS AND APPEARANCE
    DOCOSANOL 
    docosanol cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51672-1406
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Docosanol (UNII: 9G1OE216XY) (Docosanol - UNII:9G1OE216XY) Docosanol100 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    benzyl alcohol (UNII: LKG8494WBH)  
    LIGHT MINERAL OIL (UNII: N6K5787QVP)  
    propylene glycol (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    sucrose stearate (UNII: 274KW0O50M)  
    sucrose distearate (UNII: 33X4X4B90S)  
    Product Characteristics
    ColorWHITEScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51672-1406-31 in 1 PACKAGE10/26/2023
    12 g in 1 TUBE; Type 0: Not a Combination Product
    2NDC:51672-1406-22 in 1 PACKAGE10/26/2023
    22 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21445410/26/2023
    Labeler - Taro Pharmaceuticals U.S.A., Inc. (145186370)
    Establishment
    NameAddressID/FEIBusiness Operations
    Taro Pharmaceuticals Inc.206263295MANUFACTURE(51672-1406)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!